| Authors: |
Sohoni N; Department of Urology, Yale University, New Haven, CT., Sohoni NS; Department of Urology, Yale University, New Haven, CT., Sutherland RA; Department of Urology, Yale University, New Haven, CT., Sundaresan VM; Department of Urology, Yale University, New Haven, CT., Smani S; Department of Urology, Yale University, New Haven, CT., Ananth P; Department of Pediatrics, Yale University, New Haven, CT; Yale Cancer Outcomes, Public Policy and Effectiveness Research Center, New Haven, CT, USA., Onofrey JA; Department of Urology, Yale University, New Haven, CT; Department of Radiology & Biomedical Imaging, Yale University, New Haven, CT; Department of Biomedical Engineering, Yale University, New Haven, CT., Aneja S; Department of Biomedical Engineering, Yale University, New Haven, CT; Department of Therapeutic Radiology, Yale University, New Haven, CT; Center for Outcomes Research and Evaluation, Yale University, New Haven, CT., Miszczyk M; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Collegium Medicum Faculty of Medicine, WSB University, Dąbrowa Górnicza, Poland., Lee HJ; Department of Genetics and Yale Center for Genome Analysis, Yale University, New Haven, CT., Olivieri JE; Department of Computer Science, University of the Pacific, Stockton, CA., Leapman MS; Department of Urology, Yale University, New Haven, CT. Electronic address: michael.leapman@yale.edu. |
